Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29464015
Publication Date : //

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).


Hepatocellular carcinoma (HCC) remains a significant clinical challenge with few therapeutic options. Genomic amplification and/or overexpression of the MYC oncogene is a common molecular event in HCC, thus making it an attractive target for drug therapy. Unfortunately, currently there are no direct drug therapies against MYC. As an alternative strategy, microRNAs regulated by MYC may be downstream targets for therapeutic blockade. MiR-17 family is a microRNA family transcriptionally regulated by MYC and it is commonly overexpressed in human HCCs. In this study, we performed systemic delivery of a novel lipid nanoparticle (LNP) encapsulating an anti-miR-17 oligonucleotide in a conditional transgenic mouse model of MYC driven HCC. Treatment with anti-miR-17 , but not with a control anti-miRNA, resulted in significant de-repression of direct targets of miR-17, robust apoptosis, decreased proliferation and led to delayed tumorigenesis in MYC-driven HCCs. Global gene expression profiling revealed engagement of miR-17 target genes and inhibition of key transcriptional programs of MYC, including cell cycle progression and proliferation. Hence, anti-miR-17 is an effective therapy for MYC-driven HCC.

Authors : Dhanasekaran Renumathy , Gabay-Ryan Meital , Baylot Virginie , Lai Ian , Mosley Adriane , Huang Xinqiang , Zabludoff Sonya , Li Jian , Kaimal Vivek , Karmali Priya , Felsher Dean W ,

Related products :

Catalog number Product name Quantity
EIAAB46725 HCCA2,Hepatocellular carcinoma susceptibility protein,Hepatocellular carcinoma-associated protein 2,Homo sapiens,Human,YY1AP,YY1AP1,YY1-associated protein 1
29-665 The down-regulation of C9orf127 may be closely associated with tumorigenesis and metastasis of colorectal carcinoma. However, it may not contribute to the development and progression of gastric carcin 0.05 mg
29-756 The down-regulation of C9orf127 may be closely associated with tumorigenesis and metastasis of colorectal carcinoma. However, it may not contribute to the development and progression of gastric carcin 0.1 mg
29-666 The down-regulation of C9orf127 may be closely associated with tumorigenesis and metastasis of colorectal carcinoma. However, it may not contribute to the development and progression of gastric carcin 0.05 mg
MO-T40006A mAb anti-Human Hepatocellular Carcinoma Primary antibodies 0.5 mg
Y050958 Anti-Human Hepatocellular Carcinoma [CHALV1] antibody 250ug
Y050958 Anti-Human Hepatocellular Carcinoma [CHALV1] Antibody 100μg
Y050959 Anti-Human Hepatocellular Carcinoma [CHALV2] Antibody 100μg
Y050959 Anti-Human Hepatocellular Carcinoma [CHALV2] antibody 250ug
Y050960 Anti-Human Hepatocellular Carcinoma [CHALV3] antibody 250ug
Y050960 Anti-Human Hepatocellular Carcinoma [CHALV3] Antibody 100μg
BS03013 Hepatocellular carcinoma tissue array, 22 cases_63 cores; ihc Anti-AFP confirmed
BS03014 Hepatocellular carcinoma tissue array, 63 cases_63 cores, replaced by LV809; ihc Anti-AFP confirmed
DM1016 Hepatocellular Carcinoma 0.5 mg
DM1016 Hepatocellular Carcinoma 0.5 mg
DM1016 Hepatocellular Carcinoma 0.5 mg
BS03011 Hepatocellular carcinoma tissue array, 21 cases_63 cores, replaced by LV804; ihc Anti-PCNA confirmed
LV961 Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases_96 cores; ihc Anti-Cytokeratin (CK) confirmed
LV1501 Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
LV721 Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed
HCL-1211 Human HepG2 (Hepatocellular Carcinoma) lysate 100ug
E4231h Human Hepatocellular Carcinoma Related Protein 1 E 96T
EH1333 Hepatocellular carcinoma-associated protein TD26 Elisa Kit 96T
18-003-43529 Hepatocellular carcinoma-associated antigen HCA108 - N_A Polyclonal 0.05 mg Aff Pur
18-003-43798 Hepatocellular carcinoma-associated antigen HCA108 - N_A Polyclonal 0.05 mg Aff Pur


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur